SBIR/STTR Research Award
Low-cost conductimetric biosensor for detection of multiple bioterrorism agents
Award amount
$79,941Program and phase
SBIR · Phase IAward year
2007Award details
- Awarding agency
- Department of Agriculture
- Branch
- Not reported
- Recipient company
- RAPID BIOSENSE
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Combating bioterrorism effectively will require diagnostic devices that can detect potential bioterrorism
agents quickly with a high level of specificity and simplicity in any sample matrix. The longterm
goal is to develop a novel multi-array immunosensor to be used as an immediate response
device in veterinary hospitals and diagnostic labs for detection of bacteria, viruses, and toxins.
In Phase I, a proof-of-concept rapid diagnostic device will be developed in collaboration with USDA
and North Dakota State University to detect Mycobacterium paratuberculosis (MAP) in milk and
fecal samples. The device will be easy to use, sensitive, specific, and affordable. The proposed sensor
technology, invented at Michigan State University, uses a molecular wire-based conductimetric detection
technique to produce qualitative results in 6 minutes with a sensitivity of 79 cells/ml for
bacteria. To demonstrate the feasibility of the technology for bioterrorism preparedness, three specific
aims are proposed: fabrication of a single-sample biosensor for MAP detection in liquid culture
biosensor testing for MAP in spiked and well characterized fecal samples and biosensor testing for
MAP in spiked (raw and pasteurized) milk and market milk samples. Monoclonal antibodies specific
to MAP developed by Dr. John Bannantine at USDA will be used.
The Phase II program will involve sensor improvements to lower biosensor sensitivity, extensive
testing of the single-sample beta-prototype sensor by USDA-approved diagnostic labs, and development
of the field-ready multi-array prototype diagnostic device. The technology is also easily
adaptable for human diagnostics using appropriate antibodies and sample processing protocols.
Technology keywords
Not reported